NO20004312L - Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med forskjellige heterocycliske ringsystemer - Google Patents

Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med forskjellige heterocycliske ringsystemer

Info

Publication number
NO20004312L
NO20004312L NO20004312A NO20004312A NO20004312L NO 20004312 L NO20004312 L NO 20004312L NO 20004312 A NO20004312 A NO 20004312A NO 20004312 A NO20004312 A NO 20004312A NO 20004312 L NO20004312 L NO 20004312L
Authority
NO
Norway
Prior art keywords
naoh
preparation
solvent
koh
formula
Prior art date
Application number
NO20004312A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004312D0 (no
Inventor
Timothy Norris
Megan Elizabeth Hnatow
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20004312D0 publication Critical patent/NO20004312D0/no
Publication of NO20004312L publication Critical patent/NO20004312L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20004312A 1999-08-31 2000-08-30 Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med forskjellige heterocycliske ringsystemer NO20004312L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15161099P 1999-08-31 1999-08-31

Publications (2)

Publication Number Publication Date
NO20004312D0 NO20004312D0 (no) 2000-08-30
NO20004312L true NO20004312L (no) 2001-03-01

Family

ID=22539510

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004312A NO20004312L (no) 1999-08-31 2000-08-30 Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med forskjellige heterocycliske ringsystemer

Country Status (33)

Country Link
EP (1) EP1081144A3 (ja)
JP (1) JP2001106686A (ja)
KR (1) KR20010050274A (ja)
CN (1) CN1286251A (ja)
AP (1) AP2000001909A0 (ja)
AR (1) AR022650A1 (ja)
AU (1) AU5370200A (ja)
BG (1) BG104730A (ja)
BR (1) BR0003888A (ja)
CA (1) CA2316748A1 (ja)
CO (1) CO5180623A1 (ja)
CZ (1) CZ20003159A3 (ja)
EA (1) EA200000803A3 (ja)
EE (1) EE200000513A (ja)
GT (1) GT200000144A (ja)
HR (1) HRP20000565A2 (ja)
HU (1) HUP0003437A3 (ja)
ID (1) ID27128A (ja)
IL (1) IL138089A0 (ja)
IS (1) IS5604A (ja)
MA (1) MA26750A1 (ja)
NO (1) NO20004312L (ja)
NZ (1) NZ506633A (ja)
OA (1) OA11451A (ja)
PA (1) PA8499601A1 (ja)
PE (1) PE20010523A1 (ja)
PL (1) PL342280A1 (ja)
SG (1) SG87145A1 (ja)
SK (1) SK12862000A3 (ja)
SV (1) SV2002000160A (ja)
TN (1) TNSN00176A1 (ja)
TR (1) TR200002530A2 (ja)
UY (1) UY26315A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112837A1 (ja) * 2003-05-23 2004-12-29 Hisamitsu Pharmaceutical Co., Inc. 非ステロイド系消炎鎮痛剤含有外用経皮製剤およびインターロイキン－１α生成抑制剤
EP1834953A1 (en) * 2006-03-14 2007-09-19 Ranbaxy Laboratories Limited Tetrahydropyrane derivatives as 5-lipoxygenase inhibitors
CN103980312B (zh) * 2014-05-27 2016-09-07 广州大学 一种n杂环双膦配体及其合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK281577B6 (sk) * 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze

Also Published As

Publication number Publication date
EP1081144A3 (en) 2001-04-11
EA200000803A2 (ru) 2001-04-23
SG87145A1 (en) 2002-03-19
SK12862000A3 (sk) 2002-02-05
CZ20003159A3 (cs) 2001-12-12
PA8499601A1 (es) 2002-02-21
AP2000001909A0 (en) 2000-09-30
AR022650A1 (es) 2002-09-04
TR200002530A2 (tr) 2001-04-20
PE20010523A1 (es) 2001-04-28
JP2001106686A (ja) 2001-04-17
MA26750A1 (fr) 2004-12-20
EP1081144A2 (en) 2001-03-07
CN1286251A (zh) 2001-03-07
HU0003437D0 (en) 2000-08-30
HUP0003437A3 (en) 2002-08-28
BG104730A (en) 2001-09-28
IS5604A (is) 2001-03-01
HUP0003437A2 (hu) 2001-06-28
IL138089A0 (en) 2001-10-31
ID27128A (id) 2001-03-01
NZ506633A (en) 2001-12-21
CA2316748A1 (en) 2001-02-28
NO20004312D0 (no) 2000-08-30
UY26315A1 (es) 2001-04-30
OA11451A (en) 2003-12-08
KR20010050274A (ko) 2001-06-15
CO5180623A1 (es) 2002-07-30
EE200000513A (et) 2001-04-16
GT200000144A (es) 2002-02-20
HRP20000565A2 (en) 2001-06-30
TNSN00176A1 (fr) 2005-11-10
SV2002000160A (es) 2002-01-23
EA200000803A3 (ru) 2001-06-25
PL342280A1 (en) 2001-03-12
BR0003888A (pt) 2001-12-11
AU5370200A (en) 2001-03-08

Similar Documents

Publication Publication Date Title
Huang et al. Asymmetric copper-catalyzed propargylic amination with amine hydrochloride salts
Philippova et al. Synthesis of α-CF 3-substituted E-dehydroornithine derivatives via copper (i)-catalyzed hydroamination of allenes
NO20004312L (no) Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med forskjellige heterocycliske ringsystemer
IL133814A0 (en) Process for the preparation of 1-aryl-3-cyclopropyl-1, 3-propanediones
IL114676A (en) Methods for preparing multicarbide powders for hard materials
JPH03258773A (ja) Ｎ‐置換環状アミンの製法
EP0370730A3 (en) Method of producing ethylenediamines
CN111116358A (zh) 一种基于苯甲酰甲酸的苯环多取代化合物的新型合成方法
JPS6121465B2 (ja)
CA2296902A1 (en) Process for the preparation of organic azides
JPS57120600A (en) Nitrosourea derivative and its preparation
CN109485647A (zh) 一种抗焦虑药物帕戈隆或帕秦克隆的制备方法
CN112028852B (zh) 一种3-酰基异噁唑类化合物及其制备方法
JPS5673060A (en) Preparation of indoel or indole derivative
HU9603178D0 (en) Process for producing benzyl-ethers with phase transformation
JPS5686154A (en) Preparation of indole or its derivative
JPS57149246A (en) Preparation of methyl formate
CN105693726A (zh) 一种吡啶基桥联双吡唑苯并二咪唑化合物及其合成方法
JPS5679651A (en) Preparation of benzaldehyde derivative
JPS5622735A (en) Preparation of carboxylic acid amide
CN113501788A (zh) 一种n-氰乙基咪唑类化合物的合成方法
JPS51115402A (en) Process for preparation of alpha-amino acid
RU97101086A (ru) Усовершенствованный способ аминирования пиридиновых оснований по чичибабину
CN109096138A (zh) 一种合成α-胺基酮衍生物的方法
JPS54145632A (en) Preparation of 2-cyanophenol derivative

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application